Andrew Czysz, M.D., Ph.D., is an Assistant Professor in the Department of Psychiatry at UT Southwestern Medical Center. Dr. Czysz earned both his medical degree and a doctoral degree in neuroscience at the University of Illinois at Chicago. He then completed a research-track residency in psychiatry at UT Southwestern. Certified by the American Board of Psychiatry and Neurology, he joined the UT Southwestern faculty in 2019.

Dr. Czysz has published numerous academic articles and is involved with several clinical trials and other research projects related to depression at the Center for Depression Research and Clinical Care. His work includes understanding novel treatments for depression, such as esketamine and rTMS. He also studies the use of biomarkers to better understand the biology of depression in order to help match patients with the best treatment.

In 2019, he earned a New Investigator Award from the American Society of Clinical Psychopharmacology.


Medical School
University of Illinois College of Medicine at Chicago (2015)
UT Southwestern Medical Center (2019), Psychiatry

Research Interest

  • Biomarkers in Depression
  • Esketamine
  • Neuromodulation
  • rTMS
  • Treatment Resistant Depression


Featured Publications LegendFeatured Publications

G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids.
Czysz AH, Rasenick MM, CNS Neurol Disord Drug Targets 2013 Jun 12 4 466-73


Featured Books Legend Featured Books

Honors & Awards

  • American Society of Clinical Psychopharmacology New Investigator Award